Day: November 6, 2019

Société anonyme au capital de 112 324 548,80 eurosSiège social : 14, rue Royale, 75008 Paris632 012 100 R.C.S. ParisLegal Entity Identifyer : 529900JI1GG6F7RKVI53 Disclosure of total number of voting rights and number of sharesin the capital at 31 october 2019 Pursuant to article L-233-8 II of the French “Code de Commerce” and 223-16 of the AMF’s General Regulations: (*) pursuant to article 223-11 of the AMF’s General Regulations About L’Oréal

Société anonyme au capital de 112 324 548,80 eurosSiège social : 14, rue Royale, 75008 Paris632 012 100 R.C.S. ParisLegal Entity Identifyer : 529900JI1GG6F7RKVI53 Déclaration du nombre total de droits de vote et du nombre d’actions composant le capital au 31 octobre 2019 Conformément aux articles L.233-8 II du Code de commerce et 223-16 du Règlement Général de l’Autorité des Marchés Financiers.(*) en application de l’article 223-11 du Règlement Général de l’Autorité des Marchés Financiers À propos de L’Oréal

SALT LAKE CITY, Nov. 06, 2019 (GLOBE NEWSWIRE) — Quest Solution, Inc. (OTCQB: QUES) (“Quest” or “the Company”), announced the appointment of John F. Whiteman as Director of Sales.  In his new role, Mr. Whiteman will oversee the sales organization with a focus on accelerating the closing of existing sales opportunities, and meeting and exceeding sales budgets while growing the sales pipeline.  Mr. Whiteman plans to leverage his experience with the strength of the Company’s sales professionals and the support of the marketing team to drive sales growth of all of Quest’s offerings.Shai Lustgarten, CEO of Quest stated, “John is an accomplished and seasoned executive with a long track record of establishing and growing both start-ups and multi-million dollar businesses.  Many at our organization have previously worked with John given...

DALLAS, Nov. 06, 2019 (GLOBE NEWSWIRE) — via OTC PR WIRE — Kali-Extracts, Inc. (Kali, Inc. dba/Kali-Extracts, Inc.) (USOTC: KALY) (“KALY”) today announced that the company’s CBD extraction offering is beginning to see a second wave of contract opportunities.  KALY has so far announced three CBD extraction agreements with hemp farming operations worth a potential $15 million.  Under the agreements, KALY consigns the crop and harvests the hemp in addition to executing the comprehensive CBD extraction process.  As part of the agreement, KALY then agrees to produce and market the CBD consumer products made from the extracted CBD.  So far, KALY has not entered into any simple CBD extraction as a service contracts.  KALY has experienced some resistance to their “consignment” approach with hemp farming operations wanting to maintain...

LITGRID AB, company code 302564383, registered office address A. Juozapavičiaus g. 13, Vilnius, Lithuania is publishing Group results for 9 months of 2019.Revenue earned by the Litgrid group in the nine months of 2019 amounted to EUR 143.8 million, a 2.4 percent increase compared to same period of 2018. Litgrid revenue from electricity transmission increased by 5% up to EUR 51.1 million compared to 2018. Revenue from electricity transmission accounted for 36% of the Group’s total revenue.The congestion revenues reached EUR 22.5 million (EUR 12.8 million more than in 2018). This amount will be invested in the Synchronization project and will not increase the electricity transmission tariff.EBITDA in  9 months of 2019 amounted to EUR 16.6 million. Compared to 2018,  EBITDA decreased by EUR 7.8 million or 32Į. The Group’s net profit in the...

Lietuvos elektros energijos perdavimo operatorius LITGRID AB (įmonės kodas 302564383, registruotos buveinės adresas A. Juozapavičiaus g. 13, Vilnius, Lietuva) skelbia 2019 metų 9 mėnesių Grupės rezultatus.Elektros perdavimo sistemos operatoriaus „Litgrid“ įmonių grupė per pirmuosius devynis šių metų mėnesius uždirbo 143,8 mln. eurų, 2,4 procentų daugiau nei 2018 m. Pajamos už elektros perdavimą, palyginus su 2018 m., padidėjo 5 proc. iki 51,1 mln. eurų ir sudarė 36 proc. visų grupės pajamų.Išaugusiomis tarpsisteminių jungčių perkrovų valdymo įplaukomis, kurios per pirmus devynis mėnesius siekė 22,5 mln. eurų (12,8  mln. eurų didesnės nei 2018 m.), „Litgrid“ galės finansuoti investicijas į Sinchronizacijos projektą ir šios investicijos nedidins elektros perdavimo tarifo.2019 m. devynių mėnesių Grupės EBITDA buvo 16,6 mln. eurų. Lyginant...

NEW YORK, Nov. 06, 2019 (GLOBE NEWSWIRE) — iFresh, Inc. (“iFresh” or “the Company”) (NASDAQ: IFMK), a leading Asian American grocery supermarket chain and online grocer, announced today that its board of directors approved the termination of a Share Exchange Agreement (the “Exchange Agreement”) with Xiaotai International Investment Inc. (“Xiaotai”) due to an ongoing investigation of Xiaotai on alleged illegal fundraising from the public by the Hangzhou Police Department, Binjiang Branch (“Hangzhou Police”). iFresh entered into the Exchange Agreement with Xiaotai on June 7, 2019.On November 5, 2019, after the iFresh’s board of directors voted to terminate the Exchange Agreement, iFresh issued a written notice to Xiaotai International and Xiaotai Shareholders to notify them the Exchange Agreement had been terminated,...

Bagsværd, Denmark, 6 November 2019 — This document discloses the data of the transaction(s) made in Novo Nordisk shares by the company’s board members, executives and their associated persons in accordance with Article 19 of Regulation No. 596/2014 on market abuse.The company’s board members, executives and their associated persons have given Novo Nordisk power of attorney on their behalf to publish trading in Novo Nordisk shares by the company’s board members, executives and their associated persons.Further informationCompany announcement No 66 / 2019AttachmentCompany announcement No 66 / 2019

November 6, 2019; Copenhagen, Denmark;Interim Report for the First Nine Months Ended September 30, 2019HighlightsCompletion of public offering and listing of American Depository Shares (ADSs) on Nasdaq Global Select Market under the symbol “GMAB.” Total gross proceeds from the issuance of new shares amounted to USD 582 million (DKK 3,873 million) with a corresponding increase in share capital of 3,277,500 ordinary shares or 32,775,000 ADSsPositive data reported by Novartis for the Phase III ASCLEPIOS I & II studies of subcutaneous ofatumumab in relapsing multiple sclerosis (RMS)DARZALEX® (daratumumab) approved in the U.S. in combination with bortezomib, thalidomide and dexamethasone (VTd) and in Japan in combination with bortezomib, melphalan and prednisone (VMP) in various multiple myeloma frontline settingsPositive topline results...

In week 44 Arion Bank purchased own shares on Nasdaq Iceland and Swedish Depository Receipts (SDR) on Nasdaq Stockholm. See further details below.Share buyback on Nasdaq IcelandBuyback of SDR’s on Nasdaq StockholmThe transactions are carried out in accordance with the Bank’s share buyback program that was announced on both stock exchanges on 31 October 2019 and initiated on the same day.The Bank held 299,899 of own shares prior to the transactions. The Bank holds 799,899 shares and 73,814 SDR’s after the transactions or 0.03% of outstanding shares in the Bank.In accordance with the buyback program a maximum of 59,000,000 shares/SDRs in total will be purchased, corresponding to 3.25% of the current issued share capital. It is planned to purchase up to 20,650,000 SDRs in Sweden, corresponding to 1.14% of the current issued capital, and...